Pub. Date : 2009
PMID : 19374459
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Two classes of medications have been approved by the US FDA for the treatment of Alzheimer"s disease: the cholinesterase inhibitors (tacrine, donepezil, rivastigmine, galantamine), mostly for mild to moderate Alzheimer"s disease, and the noncompetitive NMDA receptor antagonist memantine for the moderate to severe stages of Alzheimer"s disease. | Galantamine | butyrylcholinesterase | Homo sapiens |